This inventor holds 1 USPTO granted patent. Top assignee: Auburn University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations of Charles White in Contact Lens Technology
Introduction
Charles White is an accomplished inventor based in Pensacola, FL (US). He has made significant contributions to the field of contact lens technology, particularly in the development of drug delivery systems. His innovative approach has the potential to enhance the comfort and effectiveness of contact lenses.
Latest Patents
Charles White holds a patent for "Extended or continuous wear silicone hydrogel contact lenses for the extended release of comfort molecules." This patent describes a drug delivery system that utilizes a recognitive polymeric hydrogel to deliver drugs by contacting biological tissue. The hydrogel is formed using a bio-template, which is either a drug or structurally similar to it, along with functionalized monomers that have complexing sites. These complexing sites mimic receptor sites of target biological tissues, facilitating biological recognition and action. The system is designed specifically for contact lenses that deliver drugs through contact with the eye.
Career Highlights
Charles White is affiliated with Auburn University, where he continues to engage in research and development in the field of biomedical engineering. His work focuses on creating innovative solutions that improve the quality of life for individuals who rely on contact lenses.
Collaborations
Some of his notable coworkers include Mark E Byrne and Maryam Ali, who contribute to the collaborative efforts in advancing research and innovation in contact lens technology.
Conclusion
Charles White's contributions to the field of contact lenses exemplify the intersection of innovation and healthcare. His patented technology not only enhances comfort but also represents a significant advancement in drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
